OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

被引:13
作者
Bachmann, Freya [1 ]
Koch, Gilbert [2 ]
Pfister, Marc [2 ]
Szinnai, Gabor [3 ]
Schropp, Johannes [1 ]
机构
[1] Univ Konstanz, Dept Math & Stat, Constance, Germany
[2] Univ Basel, Univ Childrens Hosp Basel, Pediat Pharmacol & Pharmacometr, Basel, Switzerland
[3] Univ Basel, Univ Childrens Hosp Basel, Pediat Endocrinol & Diabetol, Basel, Switzerland
关键词
Optimal control; Model predictive control; Quasi-Newton methods; Individualized optimal drug dosing; Pharmacokinetic– pharmacodynamic models; MODELS; TUTORIAL;
D O I
10.1007/s10957-021-01819-w
中图分类号
C93 [管理学]; O22 [运筹学];
学科分类号
070105 ; 12 ; 1201 ; 1202 ; 120202 ;
摘要
Providing the optimal dosing strategy of a drug for an individual patient is an important task in pharmaceutical sciences and daily clinical application. We developed and validated an optimal dosing algorithm (OptiDose) that computes the optimal individualized dosing regimen for pharmacokinetic-pharmacodynamic models in substantially different scenarios with various routes of administration by solving an optimal control problem. The aim is to compute a control that brings the underlying system as closely as possible to a desired reference function by minimizing a cost functional. In pharmacokinetic-pharmacodynamic modeling, the controls are the administered doses and the reference function can be the disease progression. Drug administration at certain time points provides a finite number of discrete controls, the drug doses, determining the drug concentration and its effect on the disease progression. Consequently, rewriting the cost functional gives a finite-dimensional optimal control problem depending only on the doses. Adjoint techniques allow to compute the gradient of the cost functional efficiently. This admits to solve the optimal control problem with robust algorithms such as quasi-Newton methods from finite-dimensional optimization. OptiDose is applied to three relevant but substantially different pharmacokinetic-pharmacodynamic examples.
引用
收藏
页码:46 / 65
页数:20
相关论文
共 33 条
[1]   Bifurcation thresholds and optimal control in transmission dynamics of arboviral diseases [J].
Abboubakar, Hamadjam ;
Kamgang, Jean Claude ;
Nkamba, Leontine Nkague ;
Tieudjo, Daniel .
JOURNAL OF MATHEMATICAL BIOLOGY, 2018, 76 (1-2) :379-427
[2]  
Bonate PL, 2011, PHARMACOKINETIC-PHARMACODYNAMIC MODELING AND SIMULATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-9485-1_1
[3]   A tutorial on the deterministic Impulse Control Maximum Principle: Necessary and sufficient optimality conditions [J].
Chahim, Mohammed ;
Hartl, Richard F. ;
Kort, Peter M. .
EUROPEAN JOURNAL OF OPERATIONAL RESEARCH, 2012, 219 (01) :18-26
[4]  
D'Argenio, 2010, CLIN PHARMACOL THER, V50, P1
[5]   COMPARISON OF 4 BASIC MODELS OF INDIRECT PHARMACODYNAMIC RESPONSES [J].
DAYNEKA, NL ;
GARG, V ;
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (04) :457-478
[6]   A Mathematical Model for the Rational Design of Chimeric Ligands in Selective Drug Therapies [J].
Doldan-Martelli, V. ;
Guantes, R. ;
Miguez, D. G. .
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2013, 2 (02)
[7]  
Gibaldi M, 1982, PHARMACOKINETICS
[8]   Utilisation of pharmacokinetic-pharmacodynamic modelling and simulation in regulatory decision-making [J].
Gobburu, JVS ;
Marroum, PJ .
CLINICAL PHARMACOKINETICS, 2001, 40 (12) :883-892
[9]  
Grüne L, 2011, COMMUN CONTROL ENG, P43, DOI 10.1007/978-0-85729-501-9_3
[10]  
Hackbusch W., 2003, Elliptic Differential Equations: Theory and Numerical Treatment, Vsecond